Basic information Uses Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Fluoropyridine >  3,5-Difluoro-4-pyridinecarboxaldehyde

3,5-Difluoro-4-pyridinecarboxaldehyde

Basic information Uses Safety Supplier Related

3,5-Difluoro-4-pyridinecarboxaldehyde Basic information

Product Name:
3,5-Difluoro-4-pyridinecarboxaldehyde
Synonyms:
  • 3,5-Difluoro-4-pyridinecarboxaldehyde
  • 3,5-Difluoropyridine-4-carboxaldehyde, 3,5-Difluoro-4-formylpyridine
  • 3,5-Difluoropyridine-4-carboxaldehyde 3,5-Difluoro-4-pyridinecarboxaldehyde
  • 2,6-difluoroisonicotinaldehyde
  • 3,5-Difluoroisonicotinaldehyde 98%
  • 4-Pyridinecarboxaldehyde, 3,5-difluoro-
  • 3,5-Difluoro-4-pyridinecarboxaldehyde ISO 9001:2015 REACH
  • (5-fluoro-4-(methylsulfonyl)pyridin-3-yl)boronic acid
CAS:
870234-98-3
MF:
C6H3F2NO
MW:
143.09
Product Categories:
  • organic building block
  • pharmacetical
  • Fluorinated
  • Organohalides
  • Pyridine
Mol File:
870234-98-3.mol
More
Less

3,5-Difluoro-4-pyridinecarboxaldehyde Chemical Properties

Melting point:
51-52℃
Boiling point:
169℃
Density 
1.392
Flash point:
56℃
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-1.60±0.28(Predicted)
Appearance
Light yellow to yellow Solid
InChI
InChI=1S/C6H3F2NO/c7-5-1-9-2-6(8)4(5)3-10/h1-3H
InChIKey
RLAOKDGTZKSUJB-UHFFFAOYSA-N
SMILES
C1=NC=C(F)C(C=O)=C1F
More
Less

Safety Information

HS Code 
2933399990
More
Less

3,5-Difluoro-4-pyridinecarboxaldehyde Usage And Synthesis

Uses

3,5-Difluoropyridine-4-carboxaldehyde is an aldehyde organic compound that can be used as a pharmaceutical intermediate.

Synthesis

107-31-3

71902-33-5

870234-98-3

General procedure for the synthesis of 3,5-difluoropyridine-4-carbaldehyde from methyl formate and 3,5-difluoropyridine: Preparation of Example 10: N-[(3,5-difluoro-4-pyridinyl)methyl]-2-(trifluoromethyl)pyridine-3-carboxamide (Compound A126) Step 1: Synthesis of 3,5-difluoropyridine-4-carbaldehyde A 2M solution of LDA (47.792 mL, 95.58 mmol) was diluted with 50 mL of THF at 0°C and cooled to -78°C. Subsequently, a 100 mL THF solution of 3,5-difluoropyridine (7.886 mL, 86.89 mmol) was added dropwise, keeping the temperature lower than -70°C (the dropwise addition process was controlled to be completed within 20 min). The reaction mixture formed a yellow suspension. Stirring was continued at -78°C for 3 hours. Then, 25 mL of THF solution of methyl formate (10.8 mL, 173.79 mmol) was added and the reaction mixture was transformed into a light yellow solution and stirred at -75°C for 45 minutes. The reaction mixture was transferred by cannula to 100 mL of stirred saturated aqueous NaHCO3 solution, maintained at about 0°C. The solution was extracted with EtOAc, the organic phases were combined and washed with brine and dried with 1N HCl. The solvent was evaporated at 165 mbar, 30°C to give 36.7 g of yellow liquid crude product. The crude product was purified by fast chromatography (eluent: CH2Cl2) to give a light yellow oil (7.85 g), which was crystallized after standing. 1H-NMR (CDCl3) data: δ 10.4 (s, 1H), 8.57 (s, 2H).

References

[1] Patent: US2014/128386, 2014, A1. Location in patent: Paragraph 1410; 1411; 1412; 1413; 1414
[2] Patent: US2017/57954, 2017, A1. Location in patent: Paragraph 0630; 0631; 0632; 0633; 0634
[3] Patent: US2009/286800, 2009, A1. Location in patent: Page/Page column 107-108
[4] Patent: WO2013/64521, 2013, A1. Location in patent: Page/Page column 112
[5] Patent: US2017/217954, 2017, A1

3,5-Difluoro-4-pyridinecarboxaldehydeSupplier

Nanjing Chengqian Pharmaceutical Technology Co., Ltd. Gold
Tel
025-52791040 18652036685
Email
haozhongwen@126.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
PharmaBlock Sciences (Nanjing),Inc.
Tel
025-86918202 4000255188
Email
sales@pharmablock.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18